TKP
ABBV icon

Tallon Kerry Patrick’s AbbVie ABBV Stock Holding History

Tallon Kerry Patrick’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$309K Buy
+1,721
New +$316K 0.3% 59

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Tallon Kerry Patrick's ABBV Position: Q4 2024 in Review

Tallon Kerry Patrick opened a new position in AbbVie (ABBV) in Q4 2024: 1,721 shares worth $309K. The stake represents 0.3% of the portfolio and ranks #59 among its holdings.

3,750 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • Tallon Kerry Patrick held 1,721 shares of AbbVie worth $309K as of Q4 2024.
  • AbbVie was a new Tallon Kerry Patrick position in Q4 2024.
  • AbbVie made up 0.3% of Tallon Kerry Patrick's portfolio in Q4 2024, its #59 holding.
  • 3,750 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on Tallon Kerry Patrick's 13F filing for Q4 2024, filed 15 Jan 2025.